Clinical trial
Dexamethasone and Chemotherapy With or Without Plasma Exchange in Patients With…
NCT00416897 · University of Glasgow, Other · Completed
Key facts
| NCT number | NCT00416897 |
|---|---|
| Title | Dexamethasone and Chemotherapy With or Without Plasma Exchange in Patients With Newly Diagnosed Multiple Myeloma and Acute Kidney Failure |
| Official title | A Randomised Controlled Trial of Adjunctive Plasma Exchange in Patients With Newly Diagnosed Multiple Myeloma and Acute Renal Failure [MERIT] MyEloma Renal Impairment Trial |
| Lead sponsor | University of Glasgow, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Multiple Myeloma and Plasma Cell Neoplasm, Renal Failure |
| Intervention type | Drug, Procedure |
| Interventions | chemotherapy, dexamethasone, plasmapheresis |
| Enrollment | 280 |
| Start date | Mar 1, 2003 |
| Completion | Dec 1, 2008 |
| First posted | Dec 28, 2006 |
| Last update posted | Aug 26, 2013 |
| Countries | United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: